Biosimilars: Past, Present and Future

Facing steep increases in health care costs, U.S. legislators are making a concerted effort to find new ways to reduce the costs of biologics. Learn the regulatory history, new proposed development pathways, realities and myths about biosimilars, the politics involved and what the future holds.